Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 826 AL 840

Comprehensive Perspectives on Experimental Models for Parkinson's Disease

Ke M, Chong CM, Zhu Q, Zhang K, Cai CZ, Lu JH, Qin D, Su H.

Aging Dis. 2021 Feb 1;12(1):223-246. doi: 10.14336/AD.2020.0331. eCollection 2021 Feb.

Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease

Masato A, Sandre M, Antonini A, Bubacco L.

Curr Neuropharmacol. 2021;19(10):1618-1639. doi: 10.2174/1570159X19666210203162617.

Cholesterol Trafficking in the Brain: Are We Overlooking an Important Risk Factor for Parkinson Disease?

Pes GM, Park YM, Sechi GP.

Neurology. 2021 Mar 9;96(10):465-466. doi: 10.1212/WNL.0000000000011595. Epub 2021 Feb 3.

Ferroptosis: mechanisms and links with diseases

Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, Lei P.

Signal Transduct Target Ther. 2021 Feb 3;6(1):49. doi: 10.1038/s41392-020-00428-9.

Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia

Gasca-Salas C, Fernández-Rodríguez B, Pineda-Pardo JA, Rodríguez-Rojas R, Obeso I, Hernández-Fernández F, Del Álamo M, Mata D, Guida P, Ordás-Bandera C, Montero-Roblas JI, Martínez-Fernández R, Foffani G, Rachmilevitch I, Obeso JA.

Nat Commun. 2021 Feb 3;12(1):779. doi: 10.1038/s41467-021-21022-9.

Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain

Lee H, Lee MJ, Kim EJ, Huh GY, Lee JH, Cho H.

Sci Rep. 2021 Feb 3;11(1):2950. doi: 10.1038/s41598-021-82469-w.

An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology

Tando S, Kasai T, Mizuta I, Takahashi H, Yaoi T, Saito K, Hojo T, Mizuno T, Hasegawa M, Itoh K.

Neuropathology. 2021 Jun;41(3):214-225. doi: 10.1111/neup.12723. Epub 2021 Feb 3.

Genetics of frontotemporal dementia in China

Jiang Y, Jiao B, Xiao X, Shen L.

Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):321-335. doi: 10.1080/21678421.2021.1880596. Epub 2021 Feb 4.

Gastrointestinal dysfunction in movement disorders

Sakakibara R.

Neurol Sci. 2021 Apr;42(4):1355-1365. doi: 10.1007/s10072-021-05041-4. Epub 2021 Feb 4.

Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review

Sica M, Tedesco S, Crowe C, Kenny L, Moore K, Timmons S, Barton J, O'Flynn B, Komaris DS.

PLoS One. 2021 Feb 4;16(2):e0246528. doi: 10.1371/journal.pone.0246528. eCollection 2021.

Can chronopharmacology improve the therapeutic management of neurological diseases?

Sion B, Bégou M.

Fundam Clin Pharmacol. 2021 Jun;35(3):564-581. doi: 10.1111/fcp.12659. Epub 2021 Mar 1.

Oxidative stress and regulated cell death in Parkinson's disease

Dionísio PA, Amaral JD, Rodrigues CMP.

Ageing Res Rev. 2021 May;67:101263. doi: 10.1016/j.arr.2021.101263. Epub 2021 Feb 1.

Parkinson's disease after COVID-19

Makhoul K, Jankovic J.

J Neurol Sci. 2021 Mar 15;422:117331. doi: 10.1016/j.jns.2021.117331. Epub 2021 Jan 28.

Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models

Trombetta-Lima M, Sabogal-Guáqueta AM, Dolga AM.

Cell Calcium. 2021 Mar;94:102362. doi: 10.1016/j.ceca.2021.102362. Epub 2021 Jan 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias